Cite
PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE-LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS
MLA
Elisa Donato, et al. “Pb1759: Retained Functional Normal And/Or Pre-Leukemic Hscs in the Bone Marrow Are Associated to Good Prognosis in Dnmt3amutnpm1mut Aml Patients.” HemaSphere, vol. 7, Aug. 2023. EBSCOhost, https://doi.org/10.1097/01.HS9.0000973892.06701.e1.
APA
Elisa Donato, Nadia Correia, Carolin Andresen, Darja Karpova, Roberto Würth, Corinna Klein, Markus Sohn, Adriana Przybylla, Petra Zeisberger, Kathrin Rothfelder, Helmut Salih, Halvard Bonig, Sebastian Stasik, Christoph Röllig, Anna Dolnik, Lars Bullinger, Frank Buchholz, Christian Thiede, Daniel Hübschmann, & Andreas Trumpp. (2023). Pb1759: Retained Functional Normal And/Or Pre-Leukemic Hscs in the Bone Marrow Are Associated to Good Prognosis in Dnmt3amutnpm1mut Aml Patients. HemaSphere, 7. https://doi.org/10.1097/01.HS9.0000973892.06701.e1
Chicago
Elisa Donato, Nadia Correia, Carolin Andresen, Darja Karpova, Roberto Würth, Corinna Klein, Markus Sohn, et al. 2023. “Pb1759: Retained Functional Normal And/Or Pre-Leukemic Hscs in the Bone Marrow Are Associated to Good Prognosis in Dnmt3amutnpm1mut Aml Patients.” HemaSphere 7 (August). doi:10.1097/01.HS9.0000973892.06701.e1.